CVSI - CV Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
5.69
+0.04 (+0.71%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close5.65
Open5.71
Bid0.00 x 0
Ask0.00 x 0
Day's Range5.61 - 5.75
52 Week Range0.66 - 9.20
Volume410,166
Avg. Volume1,118,198
Market Cap563.361M
Beta (3Y Monthly)-0.70
PE Ratio (TTM)63.22
EPS (TTM)0.09
Earnings DateMay 13, 2019 - May 17, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • ACCESSWIRE2 days ago

    With Strong Demand, More Top Retailers are Just Beginning to Sell CBD Products

    Neiman Marcus is pushing ahead with CBD sales at some of its stores and online. Simon Property Group is partnering with Green Growth Brands to open 108 stores in its malls just in 2019. CVS will carry a line of CBD products in eight states, including California, Illinois, Colorado, and Alabama.

  • Benzinga9 days ago

    Canadian Investors Can Light Up A New Cannabis ETF Focused On US Companies

    Horizons is the company behind the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)(OTC: HMLSF), which is one of the world's largest cannabis ETFs. “HMUS will be the first ETF in the world that is solely focused on providing exposure to companies with significant business activities in, or significant exposure to, the United States marijuana or hemp industries,” according to a statement.

  • GlobeNewswire10 days ago

    CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor

    LAS VEGAS, April 15, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products,.

  • ACCESSWIRE13 days ago

    Three Companies Giving Investor the Biggest Exposure to CBD Growth

    HOUSTON, TX / ACCESSWIRE / April 12, 2019 / According to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 - a compound growth rate of 147%. Some of those companies include Lifestyle Delivery Systems Inc. (CSE: LDS)(OTC: LDSYF), Charlotte's Web Holdings Inc. (CN: CWEB)(OTC: CWBHF), and CV Sciences Inc. (NASDAQ: CVSI). Lifestyle Delivery Systems Inc.'s (LDS)(LDSYF) wholly owned subsidiary, CSPA Group just entered into an agreement to provide Mbioteq with a minimum of 120 liters of 85% THC raw distillate oil per month.

  • GlobeNewswire15 days ago

    CV Sciences, Inc. Announces Distribution Expansion Into Food, Drug and Mass Channels

    LAS VEGAS, April 10, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products, is.

  • ACCESSWIRE23 days ago

    The Up-And-Coming Cannabis Producer That's About To Double Their Production Potential

    The illicit cannabis industry is estimated at $50 billion yearly, much of which will move out of the shadows and become a legal market in the coming years. One research firm estimates the legal trade could be worth $21 billion by 2021. Item 9 Labs (INLB) could be one of these as they finish a major expansion project on their Arizona cannabis cultivation and production facility, doubling capacity.

  • 3 Best Marijuana Stocks in March: Are They Buys Now?
    Motley Fool25 days ago

    3 Best Marijuana Stocks in March: Are They Buys Now?

    Spring forward in March? These three marijuana stocks did a lot more than that.

  • ACCESSWIRE29 days ago

    Cannabis Has an Energy Problem, CLSK Has the Solution

    HENDERSON, NV / ACCESSWIRE / March 26, 2019 / The electricity consumption of cannabis grow houses is staggering when compared to business and residential use. In 2015, the average electricity consumption ...

  • ACCESSWIRElast month

    These Four Marijuana Stocks Could Test March Highs on Monday

    Leafbuyer Technologies Inc (OTC:LBUY), CV Sciences Inc (CVSI), MedMen Enterprises Inc (MMNFF) (MMEN.CN), and Terra Tech Corp (TRTC) represent 4 marijuana stocks leading the pack on Monday. More than ever, consumers depend on online resources to research the products they are interested in buying and, prior to Leafbuyer's platform, no reliable source existed for information on cannabis and related products. Leafbuyer Technologies Inc (OTC:LBUY) earlier this month announced that the total number of Greenlight platform users has reached nearly 80,000.

  • GlobeNewswirelast month

    CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer

    LAS VEGAS, March 21, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products.

  • ACCESSWIRElast month

    These Four Marijuana Stocks Could Spark Activity On Thursday

    Leafbuyer Technologies Inc (LBUY), CV Sciences Inc (CVSI), Trulieve Cannabis Corp (OTC PINK: TCNNF) (TRUL.CN), and GW Pharmaceuticals plc (NASDAQ:GWPH) represent 4 marijuana stocks leading the industry on Thursday. Nowadays, consumers depend on online resources to research the products they are interested in buying and, prior to Leafbuyer's platform, there hadn't been a reliable source for information on cannabis and related products. In recognition of this growing trend to do one's homework, Leafbuyer has become the authority on cannabis-related information.

  • Benzingalast month

    CV Sciences Skewing Successfully Thanks To CBD Sales

    Earlier this month, CV Sciences Inc (OTCMKTS: CVSI) released their financial results for the fiscal year ending on Dec. 31, 2018, posting record growth in both revenue and retail distribution. Indeed, CV Sciences finished out the fiscal year with a particularly strong fourth quarter. One of CV Sciences most popular product lines is PlusCBD Gold, which contains high concentrations of CBD instead of a mixture of CBD, CBDA, and other hemp-derived cannabinoids.

  • ACCESSWIRElast month

    Four Marijuana Stocks Surpassing Investor Expectations

    The cannabis industry has been extremely fortunate in the U.S. to see a massive amount of support across the nation. Nabis Holdings (INNPF) (NAB), Newstrike Brands Ltd (OTC PINK: NWKRF), CannTrust Holdings Inc (CTST) (TRST.TO), and CV Sciences Inc (CVSI) are 4 pot stocks that could test March highs. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.

  • ACCESSWIRElast month

    Smaller Pot Stocks You Should Know

    HENDERSON, NV / ACCESSWIRE / March 15, 2019 / The biggest marijuana stocks get the most attention. But the global marijuana market is worth $150 billion annually and that suggests there's plenty of room ...

  • OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
    PR Newswirelast month

    OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

    OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ --  OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...

  • GlobeNewswirelast month

    CV Sciences, Inc. Reports Fiscal Year-End 2018 Financial Results

    Record full year revenue LAS VEGAS, March 12, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (“CV Sciences” or the “Company”) announced today its financial results for the year ended.

  • ACCESSWIRE2 months ago

    Watch These Four Marijuana Stocks Test Their Limits On Friday

    CORAL GABLES, FL / ACCESSWIRE / March 8, 2019 / Though the marijuana stock market and its accompanying industry are still very much in their infancy, cannabis companies have managed to attract significant investor attention during the course of the first few months of 2019. The primary focus of legislators now is convincing the federal government to remove marijuana's scheduled narcotic status, so that companies can access the domestic market in its entirety and offer consumers high-quality cannabis products. The future of the cannabis industry will be bright so long as public opinion surrounding marijuana legislation remains supportive and lawmakers continue to advocate for legalization.

  • Benzinga2 months ago

    US Hemp Authority Issues First 13 Certification Seals

    The U.S. Hemp Authority, an industry group responsible for the U.S. Hemp Authority Certification Program, announced the first awards of its Certification Seal Friday to companies meeting standards for ...

  • GlobeNewswire2 months ago

    CV Sciences, Inc. Appoints Dr. Douglas MacKay as Senior Vice President of Scientific and Regulatory Affairs

    LAS VEGAS, March 01, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of industry-dominating.

  • GlobeNewswire2 months ago

    CV Sciences, Inc. to Present and Exhibit at Natural Products Expo West 2019 in Anaheim, California, March 5-9, 2019

    Company enters its 4th year exhibiting at the nation's largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product offerings. LAS VEGAS, Feb. 27, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of industry-dominating hemp CBD brand, PlusCBD Oil™, today announced that the Company will be exhibiting at Natural Products Expo West on March 5-9, 2019, in Anaheim, California.

  • GlobeNewswire2 months ago

    CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 12, 2019

    LAS VEGAS, Feb. 26, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its fourth.

  • GlobeNewswire2 months ago

    CV Sciences’ PlusCBD Oil™ Gold Softgels Named “Top Pick” by ConsumerLab.com

    Country’s top-selling hemp-derived CBD brand recognized for its purity and value; PlusCBD Oil™ products pass rigorous third-party quality testing for THC and heavy metals LAS.

  • ACCESSWIRE2 months ago

    4 Marijuana Stocks Bubbling with Excitement on Wednesday (2/13/19)

    For the future of the industry to be secured, lawmakers need to press onward with passing this type of legislation, because, ultimately, this will allow companies in the sector to continue operating and developing novel products to distribute throughout the domestic cannabis market, rather than in a select few states. Nabis Holdings (INNPF) (NAB), Canopy Growth Corp (CGC) (WEED), GW Pharmaceuticals plc (GWPH), and CV Sciences Inc (CVSI) are four cannabis companies worth keeping on your radar. Nabis Holdings (INNPF) (NAB) is a Canadian investment company determined to make strategic investments in a multitude of high-quality cash flowing assets across an array of businesses in the cannabis sector, primarily in U.S. limited license states.

  • Better Buy: Medical Marijuana vs. CV Sciences
    Motley Fool2 months ago

    Better Buy: Medical Marijuana vs. CV Sciences

    Two hemp stocks. One clear winner.

  • GlobeNewswire3 months ago

    CV Sciences, Inc. Engages ICR to Enhance Investor Relations and Corporate Communications

    LAS VEGAS, Feb. 05, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products.